How did you decide to participate in the Biomapas Academy?
The first thing that caught my attention was the Biomapas Academy poster hanging on my university’s bulletin board. Shortly afterwards, the faculty management shared Biomapas’ invitation to register for the first Biomapas Academy. I wanted to learn more about this company, so I decided to take my chances and apply to the Academy. I was thrilled when I received a call with the happy news that I had successfully passed the selection process and was invited to attend the Academy.
What was your experience during the three months?
I listened to many interesting lectures, during which we got to know the company and its areas of activity. We listened to lectures on clinical trials and their organization, pharmacovigilance, regulatory affairs, bioethics, drug registration, and more. I believe that the knowledge gained at the Academy is valuable and helpful for all participants of the Academy and their future careers.
What did the future hold for you after the Academy?
I mainly was interested in pharmacovigilance, so we agreed on an internship in this department during the summer. Interesting fact: the first Biomapas poster I saw was about pharmacovigilance! And the best thing is that after the internship, I was able to join and become a part of this great team. I am happy to be here and to learn from real professionals in this field.
What would you say to the future participants?
I want to encourage everyone who is thinking about participating in the Biomapas Academy. Being at the Academy is exciting and worthwhile. By joining the Academy, you will broaden your horizons, learn from global professionals, improve your life sciences knowledge, and gain valuable experience. I wish good luck to all participants. See you soon at Biomapas!
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
Running Pan‑European Multi‑Regional Trials with Flexible FSP Models
Discover how flexible FSP models help sponsors run multi-country clinical trials across Europe with greater control, speed, and regional alignment.
Choosing the Right QPPV Partner for EU and Global Compliance
Explore the essential functions of a QPPV and discover how to choose the right partner for pharmacovigilance.
How to achieve Multi-Region Pharmacovigilance Compliance: Critical Lessons from CIS and MENA
Explore the challenges of multi-region pharmacovigilance and learn strategies for compliance in CIS and MENA markets.
Enhancing Patient Recruitment in Niche Markets Through Clinical Trial Outsourcing
Explore clinical trial outsourcing and its role in overcoming recruitment challenges in clinical research for small biotech companies.
The use of AI/Automation in Pharmacovigilance: Ensuring Safety through Robust Processes
Discover how AI and automation are transforming pharmacovigilance, including Veeva’s signal management solutions, the role of NLP and machine learning in safety workflows, and future trends in AI.
Signal Detection: An Integrated Approach to Pharmacovigilance & Regulatory Compliance
Discover how efficient signal detection manages safety risks, ensuring compliance with global regulations.
Global Literature Review: Ensuring Safety through Robust Processes
Learn how our end-to-end GLR process enhances patient safety and supports regulatory compliance worldwide.
Site Startup Services in Clinical Trials: Leveraging Local Expertise
Learn how integrating site startup services within a flexible FSP model accelerates activation in CIS and CEE, reduces contract cycles, and improves predictability from first submission to first patient in.
Pharmacovigilance outsourcing for boosting compliance and safety for biotech companies
Explore why pharmacovigilance outsourcing is essential for biotech companies in 2025 to ensure compliance and patient safety.
Local Affiliate Services That Deliver the Best Results
Find out how local affiliate services can reduce compliance risks and support effective regulatory strategies in the pharma industry.















